fbpx

The 27 Lead Drug Molecules Acquired from Biotechs in 2021

Our team conducted a review of all  the biotech acquisitions of 2021 and distilled it down to the acquisitions of drug discovery-focused biotechs. 

Navigate the 2021 M&A Series

Here, we provide a comprehensive overview of the full series, including a PDF poster book; a complete list of the acquired lead molecules with disclosed structures that were acquired in 2021, with an accompanying deep-dive slide deck; a complete list of acquisitions of biotech companies focused on molecular drug discovery in 2021, with an accompanying deep-dive slide deck; and finally an interactive table of all the biotech acquisitions of 2021. 

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.



already a member? log in:

Join the Drug Hunter mailing list

to get free content and resources weekly. Trusted by > 5,500 drug hunters worldwide. Unsubscribe anytime.

This field is for validation purposes and should be left unchanged.
Newsletter

Join Subscribers from

…and hundreds more!